Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ifosayoka 600mg/1000mg Injection

Prescription Icon
Prescription Required

Marketer

Sayoka Pharmaceutical (OPC) Pvt Ltd

Salt Composition

Mesna (600mg) + Ifosfamide (1000mg)

Overview Ifosayoka 600mg/1000mg Injection

Ifo-600/1000 Injection, a prescription combination drug used in oncology, inhibits cancer cell proliferation and aids in tumor reduction. Administered only by a healthcare provider, self-injection is strictly prohibited. Report any allergies to this medication to your physician immediately. Common adverse effects include nausea, vomiting, alopecia, anemia, and leukopenia. Pre- and during-treatment blood tests may be required, and supplemental therapy might be necessary to address potential deficiencies. A diet rich in fruits and vegetables is recommended. Disclose all other medications, pregnancy, breastfeeding, or existing medical conditions to your doctor. Alcohol consumption should be avoided, and operating machinery or driving is strongly discouraged during treatment.

Uses of Ifosayoka 600mg/1000mg Injection

Malignant neoplasm

Major Benefits of Ifosayoka 600mg/1000mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Ifosayoka 600mg/1000mg Injection:

  • Hair loss
  • Nausea
  • Vomiting
  • Anemia (low number of red blood cells)
  • Blood in urine
  • Decreased white blood cell count
  • Increased risk of infection
  • Neurotoxicity

How to use Ifosayoka 600mg/1000mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Ifosayoka 600mg/1000mg Injection works:

Ifosfamide and Mesna, the components of Ifosayoka 600mg/1000mg Injection, act synergistically against cancer. Ifosfamide targets cancerous DNA, hindering cellular growth and replication. Mesna, a cytoprotective agent, mitigates potential bladder toxicity—hemorrhage and edema—associated with Ifosfamide's action.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ifosayoka 600mg/1000mg Injection with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Ifosayoka 600mg/1000mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Administration of Ifosayoka 600mg/1000mg Injection is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingUNSAFE

Administering Ifosayoka 600mg/1000mg Injection might induce adverse reactions that could impair driving capabilities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ifosayoka 600mg/1000mg Injection cautiously, potentially requiring a modified dosage. Medical advice is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when administering Ifosayoka 600mg/1000mg Injection. Dosage modification of Ifosayoka 600mg/1000mg Injection may be necessary. Medical advice is recommended.

What if you forget to take Ifosayoka 600mg/1000mg Injection :

Omit a scheduled dose of Ifosayoka 600mg/1000mg Injection? Seek your physician's advice.

Facts to Know About Ifosayoka 600mg/1000mg Injection

LabelValue
Developing Habits No.
Treatment Category Cancer Medications
Ifosayoka 600mg/1000mg In...
301
MRP 367
17% off